Merck & Co To Expand Through Investment

BMI View: The importance of Puerto Rico as a major production hub for multinational pharmaceutical companies will slightly deteriorate due to production quality issues, drug patent expirations, increasing labour and other operational costs, and the potential tax increase from the local government. However, the pharmaceutical industry will still be an economic mainstay for Puerto Rico and the incentives will continue to draw multinational drugmakers' investment, as long as their attractiveness can offset the impact of negative issues.

To read the full article, please choose one of the following options: